Holen Sie sich die Stockscreener-App
20.60
2.28%
0.46
Schlusskurs vom Vortag:
$20.14
Offen:
$20.14
24-Stunden-Volumen:
1.22M
Relative Volume:
1.40
Marktkapitalisierung:
$1.29B
Einnahmen:
$330.50M
Nettoeinkommen (Verlust:
$145.42M
KGV:
12.48
EPS:
1.65
Netto-Cashflow:
$157.96M
1W Leistung:
+7.57%
1M Leistung:
+10.04%
6M Leistung:
+8.48%
1J Leistung:
+29.56%
1-Tages-Spanne:
$20.10
$20.82
1-Wochen-Bereich:
$19.02
$20.82
52-Wochen-Spanne:
$15.55
$21.28
Innoviva Inc Stock (INVA) Company Profile
Firmenname
Innoviva Inc
Sektor
Branche
Telefon
(650) 238-9600
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Vergleichen Sie INVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.60 | 1.20B | 330.50M | 145.42M | 157.96M | 1.65 |
|
ONC
Beone Medicines Ltd Adr
|
251.72 | 25.78B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.48 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3401 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.81 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
487.86 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Eingeleitet | Goldman | Neutral |
| 2017-11-20 | Eingeleitet | Deutsche Bank | Hold |
Innoviva Inc Aktie (INVA) Neueste Nachrichten
Innoviva to Participate in Upcoming Investor Conferences - BioSpace
(INVA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $546,000 Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Ameriprise Financial Inc. Has $2.50 Million Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lifted by Millennium Management LLC - Defense World
(INVA) Proactive Strategies - news.stocktradersdaily.com
Innoviva Elects Board Members and Approves Compensation - TipRanks
Bank of America Corp DE Decreases Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections - BioSpace
Innoviva (INVA) Launches New Antibiotic ZEVTERA for MRSA Treatme - GuruFocus
ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections - marketscreener.com
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States - The Manila Times
Cubist Systematic Strategies LLC Makes New $184,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Northern Trust Corp - Defense World
Comerica Bank Sells 141,150 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Armata Completes Crucial Bacteriophage Trial, Lands $4.65M Defense Contract Amid Strong Q1 Results - Stock Titan
Innoviva’s Strong Q1 2025 Performance and Strategic Progress - TipRanks
(INVA) Investment Analysis - news.stocktradersdaily.com
Investor Network: Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Envestnet Asset Management Inc. Has $258,000 Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey
Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva: Q1 Earnings Snapshot - MySA
Innoviva Inc reports results for the quarter ended March 31Earnings Summary - TradingView
INVA Posts Strong Q1 Results with Revenue Growth and Strategic Developments | INVA Stock News - GuruFocus
BlackRock, Inc. Reduces Stake in Innoviva Inc: A Detailed Analysis - GuruFocus
Wells Fargo & Company MN Purchases 10,637 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Trading (INVA) With Integrated Risk Controls - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
Rep. George Whitesides Unloads Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rep. George Whitesides Sells Off Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Bank of Montreal Can - Defense World
StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World
Insider Selling Buzz: Innoviva Inc [INVA] 10% Owner DENNER ALEXANDER J sold 1,196,746 shares of the company - knoxdaily.com
(INVA) Trading Report - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Upgraded by StockNews.com to “Buy” Rating - Defense World
Russell Investments Group Ltd. Decreases Stake in Innoviva, Inc. (NASDAQ:INVA) - The AM Reporter
Are Innoviva, Inc.'s (NASDAQ:INVA) Mixed Financials Driving The Negative Sentiment? - Yahoo Finance
Vanguard Group Inc. Buys 84,934 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Corebridge Financial Inc. Sells 2,299 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva NASDAQ: INVA $18.07 0 (0.00%) Apr 2, 2025 4 - MarketScreener
Thrivent Financial for Lutherans Has $739,000 Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Teacher Retirement System of Texas Grows Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.com - Defense World
Where are the Opportunities in (INVA) - news.stocktradersdaily.com
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Raised by HighTower Advisors LLC - Defense World
Can Mixed Fundamentals Have A Negative Impact on Innoviva, Inc. (NASDAQ:INVA) Current Share Price Momentum? - Simply Wall St
Finanzdaten der Innoviva Inc-Aktie (INVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):